Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

被引:662
作者
Wirapati, Pratyaksha [2 ]
Sotiriou, Christos [1 ]
Kunkel, Susanne [2 ]
Farmer, Pierre [2 ,3 ]
Pradervand, Sylvain [4 ]
Haibe-Kains, Benjamin [1 ,5 ]
Desmedt, Christine [1 ]
Ignatiadis, Michail [1 ]
Sengstag, Thierry [3 ]
Schuetz, Frederic [2 ]
Goldstein, Darlene R. [2 ,4 ,6 ]
Piccart, Martine [1 ]
Delorenzi, Mauro [2 ,3 ]
机构
[1] Univ Libre Bruxelles, Translat Res & Med Oncol Unit, Inst Jules Bordet, B-1000 Brussels, Belgium
[2] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland
[3] Swiss Inst Expt Canc Res, Natl Ctr Competence Res, CH-1066 Epalinges, Switzerland
[4] Univ Lausanne, Ctr Integrat Genom, DNA Array Facil, CH-1015 Lausanne, Switzerland
[5] Free Univ Brussels, Machine Learning Grp, B-1050 Brussels, Belgium
[6] Ecole Polytech Fed Lausanne, Inst Math, CH-1015 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
D O I
10.1186/bcr2124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Breast cancer subtyping and prognosis have been studied extensively by gene expression profiling, resulting in disparate signatures with little overlap in their constituent genes. Although a previous study demonstrated a prognostic concordance among gene expression signatures, it was limited to only one dataset and did not fully elucidate how the different genes were related to one another nor did it examine the contribution of well-known biological processes of breast cancer tumorigenesis to their prognostic performance. Method To address the above issues and to further validate these initial findings, we performed the largest meta-analysis of publicly available breast cancer gene expression and clinical data, which are comprised of 2,833 breast tumors. Gene coexpression modules of three key biological processes in breast cancer ( namely, proliferation, estrogen receptor [ER], and HER2 signaling) were used to dissect the role of constituent genes of nine prognostic signatures. Results Using a meta-analytical approach, we consolidated the signatures associated with ER signaling, ERBB2 amplification, and proliferation. Previously published expression-based nomenclature of breast cancer 'intrinsic' subtypes can be mapped to the three modules, namely, the ER-/HER2(-) (basal-like), the HER2(+) (HER2-like), and the low- and high-proliferation ER+/HER2(-) subtypes (luminal A and B). We showed that all nine prognostic signatures exhibited a similar prognostic performance in the entire dataset. Their prognostic abilities are due mostly to the detection of proliferation activity. Although ER- status (basal-like) and ERBB2(+) expression status correspond to bad outcome, they seem to act through elevated expression of proliferation genes and thus contain only indirect information about prognosis. Clinical variables measuring the extent of tumor progression, such as tumor size and nodal status, still add independent prognostic information to proliferation genes. Conclusion This meta-analysis unifies various results of previous gene expression studies in breast cancer. It reveals connections between traditional prognostic factors, expression-based subtyping, and prognostic signatures, highlighting the important role of proliferation in breast cancer prognosis.
引用
收藏
页数:11
相关论文
共 43 条
[1]   High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates [J].
Alexe, Gabricla ;
Dalgin, Gul S. ;
Scanfeld, Daniel ;
Tamayo, Pablo ;
Mesirov, Jill P. ;
DeLisi, Charles ;
Harris, Lyndsay ;
Barnard, Nicola ;
Martel, Maritza ;
Levine, Arnold J. ;
Ganesan, Shridar ;
Bhanot, Gyan .
CANCER RESEARCH, 2007, 67 (22) :10669-10676
[2]  
[Anonymous], 1999, A package for survival analysis in S
[3]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[4]  
BLAMEY RW, 1996, BREAST, V5, P156
[5]   Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial [J].
Bogaerts, Jan ;
Cardoso, Fatima ;
Buyse, Marc ;
Braga, Sofia ;
Loi, Sherene ;
Harrison, Jillian A. ;
Bines, Jacques ;
Mook, Stella ;
Decker, Nuria ;
Ravdin, Peter ;
Therasse, Patrick ;
Rutgers, Emiel ;
van't Veer, Laura J. ;
Piccart, Martine .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (10) :540-551
[6]   Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].
Buyse, Marc ;
Loi, Sherene ;
van't Veer, Laura ;
Viale, Giuseppe ;
Delorenzi, Mauro ;
Glas, Annuska M. ;
d'Assignies, Mahasti Saghatchian ;
Bergh, Jonas ;
Lidereau, Rosette ;
Ellis, Paul ;
Harris, Adrian ;
Bogaerts, Jan ;
Therasse, Patrick ;
Floore, Arno ;
Amakrane, Mohamed ;
Piette, Fanny ;
Rutgers, Emiel ;
Sotiriou, Christos ;
Cardoso, Fatima ;
Piccart, Martine J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192
[7]   Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients [J].
Calza, Stefano ;
Hall, Per ;
Auer, Gert ;
Bjohle, Judith ;
Klaar, Sigrid ;
Kronenwett, Ulrike ;
T Liu, Edison ;
Miller, Lance ;
Ploner, Alexander ;
Smeds, Johanna ;
Bergh, Jonas ;
Pawitan, Yudi .
BREAST CANCER RESEARCH, 2006, 8 (04)
[8]   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival [J].
Chang, HY ;
Nuyten, DSA ;
Sneddon, JB ;
Hastie, T ;
Tibshirani, R ;
Sorlie, T ;
Dai, HY ;
He, YDD ;
van't Veer, LJ ;
Bartelink, H ;
van de Rijn, M ;
Brown, PO ;
van de Vijver, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) :3738-3743
[9]   Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds [J].
Chang, HY ;
Sneddon, JB ;
Alizadeh, AA ;
Sood, R ;
West, RB ;
Montgomery, K ;
Chi, JT ;
van de Rijn, M ;
Botstein, D ;
Brown, PO .
PLOS BIOLOGY, 2004, 2 (02) :206-214
[10]  
Clarke M, 1998, LANCET, V351, P1451